D-0085-2019 Class II Terminated
FDA drug recall D-0085-2019 was initiated by Valeant Pharmaceuticals North America LLC on Aug 24, 2018 and is designated Class II. Reason for recall: CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the… The recall status is terminated (terminated Mar 6, 2020). Affected quantity: 119,594 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 31, 2018
- Initiation Date
- Aug 24, 2018
- Termination Date
- Mar 6, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 119,594 tubes
Product description
Cortaid Maximum Strength Cream (1% hydrocortisone), 1 OZ (28 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875521011
Reason for recall
CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.
Distribution pattern
Product was distributed throughout the United States
Code information
Lot #: 170843B, Exp 2/19; 171484D, Exp 4/19; 171791E, 171848E, Exp 5/19; 172359J, 172360J, 173184J, Exp 9/19; 173512P, Exp 12/19; 180180B, Exp 2/20; 181098C, Exp 3/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0085-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026